Login

Magdalena Kayser

ORCID: 0000-0001-6387-4889
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5000417637
Research Areas
  • CAR-T cell therapy research
  • Cancer Immunotherapy and Biomarkers
  • Biosimilars and Bioanalytical Methods
  • Immunotherapy and Immune Responses
 Creating an Innovative Artificial Intelligence–Based Technology (TCRact) for Designing and Optimizing T Cell Receptors for Use in Cancer Immunotherapies: Protocol for an Observational Trial
OPENALEX - Publications 
Joanna Bujak Stanisław Kłęk Martyna Balawejder Aleksandra Kociniak Kinga Wilkus and 22 more Rafał Szatanek Zofia Orzeszko Joanna Welanyk Grzegorz Torbicz Mateusz Jęckowski Tomasz Kucharczyk Łukasz Wohadło Maciej Borys Honorata Stadnik Michał Wysocki Magdalena Kayser Marta Ewa Słomka Anna Kosmowska Karolina Horbacka Tomasz Gach Beata Markowska T. Kowalczyk Jacek Karoń Marek Karczewski Mirosław Szura Anna Sanecka-Duin Agnieszka Blum

Cancer continues to be the leading cause of mortality in high-income countries, necessitating development more precise and effective treatment modalities. Immunotherapy, specifically adoptive cell transfer T receptor (TCR)-engineered cells (TCR-T therapy), has shown promise engaging immune system for cancer treatment. One biggest challenges TCR-T therapies is proper prediction pairing between TCRs peptide-human leukocyte antigen (pHLAs). Modern computational immunology, using artificial...

10.2196/45872 article EN cc-by JMIR Research Protocols 2023-06-02
 Creating an Innovative Artificial Intelligence–Based Technology (TCRact) for Designing and Optimizing T Cell Receptors for Use in Cancer Immunotherapies: Protocol for an Observational Trial (Preprint)
OPENALEX - Publications 
Joanna Bujak Stanisław Kłęk Martyna Balawejder Aleksandra Kociniak Kinga Wilkus and 22 more Rafał Szatanek Zofia Orzeszko Joanna Welanyk Grzegorz Torbicz Mateusz Jęckowski Tomasz Kucharczyk Łukasz Wohadło Maciej Borys Honorata Stadnik Michał Wysocki Magdalena Kayser Marta Ewa Słomka Anna Kosmowska Karolina Horbacka Tomasz Gach Beata Markowska T. Kowalczyk Jacek Karoń Marek Karczewski Mirosław Szura Anna Sanecka-Duin Agnieszka Blum

<sec> <title>BACKGROUND</title> Cancer continues to be the leading cause of mortality in high-income countries, necessitating development more precise and effective treatment modalities. Immunotherapy, specifically adoptive cell transfer T receptor (TCR)-engineered cells (TCR-T therapy), has shown promise engaging immune system for cancer treatment. One biggest challenges TCR-T therapies is proper prediction pairing between TCRs peptide-human leukocyte antigen (pHLAs). Modern computational...

10.2196/preprints.45872 preprint EN 2023-02-08
Coming Soon ...